Dentsply Sirona Inc Stock Price, News & Analysis

Dentsply Sirona, a leading manufacturer of dental products, will host an investor conference call and live webcast on February 28, 2023, at 8:30 am ET. This event aims to discuss the company’s fourth quarter and full year 2022 financial results. Interested participants can find the presentation and register for the call on Dentsply Sirona's Investor Relations website at https://investor.dentsplysirona.com. A replay of the webcast will also be accessible afterward. Dentsply Sirona is headquartered in Charlotte, North Carolina, and is known for its innovative dental technologies.

Dentsply Sirona (Nasdaq: XRAY) presented at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023. The company forecasts net sales exceeding $3.88 billion, surpassing its previous outlook range of $3.85 billion to $3.88 billion. The adjusted EPS for the full year 2022 is anticipated to remain within the prior guidance of $1.90 to $2.00. Presentation materials and webcast details are accessible on the company's investor website.

DENTSPLY SIRONA (Nasdaq: XRAY) will participate in the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 10:30 am PT (1:30 pm ET). A live audio webcast of the presentation will be accessible via the company's investors section on their website. Dentsply Sirona, headquartered in Charlotte, North Carolina, is the world's largest manufacturer of professional dental products, providing innovative solutions that enhance patient care and safety.

Dentsply Sirona (Nasdaq: XRAY) has declared a quarterly cash dividend of $0.125 per share, translating to an indicated annual rate of $0.50 per share. The dividend will be payable on January 13, 2023, to shareholders on record as of December 30, 2022. This move reflects the company’s commitment to returning value to its shareholders while continuing its longstanding history in the dental industry.

Dentsply Sirona reported third-quarter 2022 net sales of $947 million, down by 8.9% year-over-year, with a GAAP loss of $5.01 per share. Adjusted EPS fell by 31.5% to $0.41. Key factors included foreign currency impacts and macroeconomic headwinds, with organic sales slightly declining by 0.7%. The company initiated a comprehensive review to enhance execution and return to growth. Full-year guidance reflects an expected organic sales decline of approximately 2% and adjusted EPS projected between $1.90 and $2.00.

Dentsply Sirona (Nasdaq: XRAY) announced its participation in two key upcoming healthcare conferences. The first is the Jefferies 13th Annual London Healthcare Conference scheduled for November 17, 2022, at 12:20 pm GMT (7:20 am ET). The second is the Evercore ISI 5th Annual HealthCONx Conference on December 1, 2022, at 1:00 pm ET. Interested investors can access live webcasts of these presentations via the Dentsply Sirona website. As the world's largest manufacturer of dental products, Dentsply Sirona focuses on innovative solutions for patient care.

Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call and live webcast on November 14, 2022, at 8:30 am ET to discuss its third quarter financial results. Investors can access a presentation on the Company's website at this link. To participate in the call, registration is required via this page. A replay of the conference call will also be available online.

As the largest manufacturer of dental products, Dentsply Sirona focuses on advancing patient care through innovative solutions.

DENTSPLY SIRONA (Nasdaq: XRAY) announced the conclusion of its internal investigation into financial reporting issues, resulting in restatements for Q3 2021 and full-year 2021. The Audit and Finance Committee identified material weaknesses in internal controls. The company expects a goodwill impairment charge between $1.0 billion and $1.3 billion due to economic factors. Preliminary Q3 2022 net sales are projected at $947 million, reflecting organic sales decline. DENTSPLY anticipates low-single-digit sequential net sales decline for Q4 2022 but expects flat growth on a constant currency basis.

Dentsply Sirona (Nasdaq: XRAY) has appointed Glenn Coleman as Executive Vice President and Chief Financial Officer, effective September 26, 2022. He succeeds Barbara Bodem, who served as Interim CFO since May 2022 and will assist Coleman until October 24, 2022. Coleman brings over 30 years of experience, having previously held executive roles at Integra Lifesciences and other global firms. CEO Simon Campion expressed confidence in Coleman’s leadership to enhance financial and operational strategies and support the company's growth initiatives.